Legend Biotech Receives Outperform Rating from Royal Bank of Canada - MarketBeat
LEGN Stock | USD 33.65 0.67 2.03% |
About 58% of all Legend Biotech's investors are looking to take a long position. The analysis of the overall investor sentiment regarding Legend Biotech Corp suggests that some traders are interested. Legend Biotech's investing sentiment overview a quick insight into current market opportunities from investing in Legend Biotech Corp. Many technical investors use Legend Biotech Corp stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Legend |
Legend Biotech Receives Outperform Rating from Royal Bank of Canada MarketBeat
Read at news.google.com
![]() |
Legend Biotech Corp Current Investor Sentiment
Comfort Level 58
Interested
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Legend Biotech's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Legend Biotech Corp.
News SentimentBullish | Hype SentimentBullish | Insider SentimentWaiting |
Legend Biotech Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Legend Biotech can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Legend Biotech Corp Historical Investor Sentiment
Investor biases related to Legend Biotech's public news can be used to forecast risks associated with an investment in Legend. The trend in average sentiment can be used to explain how an investor holding Legend can time the market purely based on public headlines and social activities around Legend Biotech Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Legend Biotech's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Legend Biotech and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Legend Biotech news discussions. The higher the estimate score, the more favorable the investor's outlook on Legend Biotech.
Legend Biotech Maximum Pain Price Across May 16th 2025 Option Contracts
Legend Biotech's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Legend Biotech close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Legend Biotech's options.
Legend Biotech Fundamental Analysis
We analyze Legend Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Legend Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Legend Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Legend Biotech is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Legend Biotech Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Legend Biotech stock to make a market-neutral strategy. Peer analysis of Legend Biotech could also be used in its relative valuation, which is a method of valuing Legend Biotech by comparing valuation metrics with similar companies.
Peers
Legend Biotech Related Equities
ZLAB | Zai Lab | 6.33 | ||||
APLS | Apellis Pharmaceuticals | 4.03 | ||||
ACLX | Arcellx | 3.80 | ||||
MDGL | Madrigal Pharmaceuticals | 2.73 | ||||
STOK | Stoke Therapeutics | 2.43 | ||||
AMLX | Amylyx Pharmaceuticals | 0.33 | ||||
TERN | Terns Pharmaceuticals | 0.00 | ||||
BPMC | Blueprint Medicines | 0.41 | ||||
TVTX | Travere Therapeutics | 0.81 | ||||
ASND | Ascendis Pharma | 0.92 | ||||
ETNB | 89bio | 1.13 | ||||
ALNY | Alnylam Pharmaceuticals | 1.23 | ||||
PCVX | Vaxcyte | 1.82 | ||||
AKRO | Akero Therapeutics | 2.15 | ||||
DAWN | Day One | 4.97 | ||||
PLRX | Pliant Therapeutics | 59.88 |
Check out Legend Biotech Hype Analysis, Legend Biotech Correlation and Legend Biotech Performance. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend Biotech. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.92) | Revenue Per Share | Quarterly Revenue Growth 0.669 | Return On Assets | Return On Equity |
The market value of Legend Biotech Corp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend Biotech's value that differs from its market value or its book value, called intrinsic value, which is Legend Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend Biotech's market value can be influenced by many factors that don't directly affect Legend Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.